Viewing nowGlimapin Tablet (Gliclazide)
Glimepiride 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 200300661 · Notified 2003.09.09 · Insurance code 642400020
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be used as monotherapy, and in some cases, can be combined with oral hypoglycemic agents or insulin. In particular, it enhances effectiveness when administered with metformin if blood sugar control is difficult with sulfonylurea drugs alone. Thus, it is used for the treatment of diabetes by assisting in blood sugar control.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering drug to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering drugs. When switching from another oral glucose-lowering drug to this medicine, it is recommended to follow the instructions given under Initial dose. That is, initiate treatment with 1 mg once daily, and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be considered. 4) Treatment monitoring Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after initial successful management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately once a week according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dose adjustment is required periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes or those with diabetic ketoacidosis or in a comatose state. Additionally, it is advisable to avoid administering this medication to patients who are allergic to this drug or sulfonylurea drugs, or those with severe liver or kidney dysfunction. Pregnant or possibly pregnant women and nursing mothers should not use this medication. Insulin therapy is recommended for patients with severe infections, before and after surgery, or those with severe trauma. Patients with gastrointestinal disorders such as diarrhea or vomiting should be cautious as these conditions can impede food absorption, increasing the risk of hypoglycemia. During the first week of administration of this medication, the risk of hypoglycemia is high, hence blood glucose levels should be closely monitored. Particularly, elderly patients, those with poor nutritional status, those who eat irregularly, those who frequently consume alcohol, and those with impaired liver or kidney function should be even more cautious. Also, when taking other medications, changes in blood sugar levels may occur, so it is essential to inform the physician or pharmacist of all current medications. This medication can cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and decreased consciousness. In case of hypoglycemia, immediate consumption of sugar-containing food is required, and if symptoms are severe or recurrent, the patient should consult a physician. During the use of this medication, symptoms such as blurred vision, indigestion, abnormal liver function, blood abnormalities, or allergic reactions may appear. If any abnormal symptoms occur, medical personnel should be notified immediately. To control blood sugar, regular intake of this medication along with dietary therapy, exercise therapy, and weight management is crucial. During the use of this medication, being informed about symptoms and risks of hypoglycemia, along with treatment methods, is important, and patients should be prepared to consume sufficient sugar. In addition, insulin therapy may need to be switched to when conditions such as stress, surgery, or infection make blood sugar control difficult. Severe hypoglycemia can occur in case of overdose, so in case of overdose, immediate emergency treatment must be obtained, and blood sugar levels should be closely monitored for at least 24 to 48 hours thereafter. This medication has not been established for safety and efficacy in children, and elderly patients may require dosage adjustment due to decreased kidney function. Finally, this medication should be kept out of the reach of children and stored in its original container.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, transient mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius. This will help preserve the effectiveness and safety of the medication for a long time.
Green rectangular tablet
30 tablets/box [(10 tablets/PTPX3)], 30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.